Symphogen symphogen.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Symphogen is developing next-generation antibody therapeutics for the treatment of cancer and is dedicated to bringing truly innovative oncology products to the market. The company has advanced the frontier of antibody discovery by creating well-characterized antibody mixtures that address multiple oncology targets in a single drug product. The company has matured its pipeline, currently has two product candidates in the clinic, and is researching promising novel immuno-oncology opportunities. ...Show all

Symphogen is developing next-generation antibody therapeutics for the treatment of cancer and is dedicated to bringing truly innovative oncology products to the market. The company has advanced the frontier of antibody discovery by creating well-char...Show all

Company (Acquired)

Phone: +45 4526 5050

Fax:

Pederstrupvej 93

Ballerup, DK-2750
Denmark

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Symphogen $364.2M Apr 3, 2020
Humanetics Corporation $0.6M Jul 23, 2020
PharmAthene $61.2M Mar 14, 2005
See all 19 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Symphogen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors

Competitors

Company Status Description Investors
See all 19 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-met antibodies and compositions Sep 15, 2015 Oct 22, 2019 Patent
Pan-her antibody composition Nov 28, 2016 Mar 05, 2019 Patent
Humanized pan-her antibody compositions Nov 14, 2016 Aug 28, 2018 Patent
Humanized pan-her antibody compositions May 02, 2013 Dec 27, 2016 Patent
Anti-her3 antibodies and compositions Oct 31, 2011 Dec 22, 2015 Patent
See all 24 patents